Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Clinical Research
Indipharm: your gateway to clinical trials in India
India is fast becoming a very attractive destination for clinical trials.
Improving Treatment for Diabetes
Dr. James Shannon of Novartis tells NGP about the advantages its new diabetes treatments will bring to patients.
Fighting heart disease
Dr. Andrew Plump of Merck & Co., Inc. tells NGP about the groundbreaking research being carried out on the treatment and prevention of cardiovascular disease.
Biotherapeutics: the way of the future?
Dr. Katherine Call of sanofi-aventis spoke to NGP about the growing significance of biotherapeutics for the pharmaceutical industry.
Translational medicine paradigm: hip or hype?
Adrian Bot, Senior Director of Scientific Management and Acting Head of Translational Medicine, at MannKind Corporation explains the basics of translational medicine.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.